Management Name : Mr SARAWUT BENJAKUL | Type of securities : Common share | Methods of Acquisition / Disposition : Buy | Transaction Date : 15/02/2017
Management Name : Mr SARAWUT BENJAKUL | Type of securities : Common share | Methods of Acquisition / Disposition : Buy | Transaction Date : 09/02/2018
Management Name : Mr SARAWUT BENJAKUL | Type of securities : Common share | Methods of Acquisition / Disposition : Buy | Transaction Date : 22/02/2018
Management Name : Mr SARAWUT BENJAKUL | Type of securities : Common share | Methods of Acquisition / Disposition : Buy | Transaction Date : 27/06/2018
Management Name : Mr SARAWUT BENJAKUL | Type of securities : Common share | Methods of Acquisition / Disposition : Buy | Transaction Date : 17/07/2018
or 22.90% over the same period of last year of which hospital revenues totally raised by 10.16% along with the enlarged customer base of Subsidiary (AMARC) showing 15.67% of revenues’ growth. In
internal audit report concerning cost of sales and inventories which were raised by the auditor. The said opinion must be submitted to the SEC within 5 working days from the date on which the audit committee
internal audit report concerning cost of sales and inventories which were raised by the auditor. The said opinion must be submitted to the SEC within 5 working days from the date on which the audit committee
statements to materially contain false information and raised doubts concerning the internal control system, spending of B/E money, and the making of accounting records.The SEC has therefore issued the order
issuance in the fourth quarter of 2015 did not appear in the company’s financial statements. Such circumstance caused KC financial statements to materially contain false information and raised doubts